Whole genome sequencing in CLL: challenges and benefits
Can we apply knowledge on CLL to other types of cancers?
Highlights from EHA 2016 press briefings: POLLUX and EURO-SKI trials and BiTE antibodies
Can we afford to have CLL patients on a therapy for the rest of their lives?
John Gribben et al.
Do Philadelphia chromosome-positive ALL patients need a stem cell transplant?